المساهمون: Youngsook Kim, Ji Hye Huh, Minyoung Lee, Eun Seok Kang, Bong-Soo Cha, Byung-Wan Lee, Kang, Eun Seok

مصطلحات موضوعية: Blood Glucose / analysis, Diabetes Mellitus, Type 2* / drug therapy, Glucagon-Like Peptide-1 Receptor / agonists, Glucagon-Like Peptides / analogs & derivatives, Humans, Immunoglobulin Fc Fragments, Insulin, Recombinant Fusion Proteins, Retrospective Studies, GLP-1 receptor agonist, insulin therapy, switching to GLP-1 receptor agonist, type 2 diabetes, type 2 diabetes inadequately controlled with insulin therapy

Relation: FRONTIERS IN ENDOCRINOLOGY; J03412; OAK-2022-03290; https://ir.ymlib.yonsei.ac.kr/handle/22282913/189538; T202202920; FRONTIERS IN ENDOCRINOLOGY, Vol.13 : 880164, 2022-06

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/189538
https://doi.org/10.3389/fendo.2022.880164

المساهمون: Hertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, Rafael Diaz, Mark Lakshmanan, Prem Pais, Jeffrey Probstfield, Fady T Botros, Matthew C Riddle, Lars Ryd챕n, Denis Xavier, Charles Messan Atisso, Leanne Dyal, Stephanie Hall, Purnima Rao-Melacini, Gloria Wong, Alvaro Avezum, Jan Basile, Namsik Chung, Ignacio Conget, William C Cushman, Edward Franek, Nicolae Hancu, Markolf Hanefeld, Shaun Holt, Petr Jansky, Matyas Keltai, Fernando Lanas, Lawrence A Leiter, Patricio Lopez-Jaramillo, Ernesto German Cardona Munoz, Valdis Pirags, Nana Pogosova, Peter J Raubenheimer, Jonathan E Shaw, Wayne H-H Sheu, Theodora Temelkova-Kurktschiev, for the REWIND Investigators, Kwon, Hyuck Moon

مصطلحات موضوعية: Aged, Albuminuria/prevention & control, Creatinine/urine, Diabetes Mellitus, Type 2/drug therapy, Diabetic Nephropathies/prevention & control, Double-Blind Method, Female, Glomerular Filtration Rate/drug effects, Glucagon-Like Peptides/analogs & derivatives, Glucagon-Like Peptides/therapeutic use, Humans, Hypoglycemic Agents/therapeutic use, Immunoglobulin Fc Fragments/therapeutic use, Male, Middle Aged, Recombinant Fusion Proteins/therapeutic use

Relation: LANCET; J02152; OAK-2019-06493; https://ir.ymlib.yonsei.ac.kr/handle/22282913/174492; https://www.sciencedirect.com/science/article/pii/S014067361931150X; T201904409; LANCET, Vol.394(10193) : 131-138, 2019

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/174492
https://doi.org/10.1016/S0140-6736(19)31150-X
https://www.sciencedirect.com/science/article/pii/S014067361931150X

المساهمون: Hertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, Rafael Diaz, Mark Lakshmanan, Prem Pais, Jeffrey Probstfield, Jeffrey S Riesmeyer, Matthew C Riddle, Lars Ryd챕n, Denis Xavier, Charles Messan Atisso, Leanne Dyal, tephanie Hall, Purnima Rao-Melacini, Gloria Wong, Alvaro Avezum, Jan Basile, Namsik Chung, Ignacio Conget, William C Cushman, Edward Franek, Nicolae Hancu, Markolf Hanefeld, Shaun Holt, Petr Jansky, Matyas Keltai, Fernando Lanas, Lawrence A Leiter, Patricio Lopez-Jaramillo, Ernesto German Cardona Munoz, Valdis Pirags, Nana Pogosova, Peter J Raubenheimer, Jonathan E Shaw, Wayne H-H Sheu, Theodora Temelkova-Kurktschiev, for the REWIND Investigators, Kwon, Hyuck Moon

مصطلحات موضوعية: Aged, Cardiovascular Diseases/mortality, Cardiovascular Diseases/prevention & control, Diabetes Mellitus, Type 2/complications, Type 2/drug therapy, Double-Blind Method, Female, Glucagon-Like Peptides/analogs & derivatives, Glucagon-Like Peptides/therapeutic use, Humans, Hypoglycemic Agents/therapeutic use, Immunoglobulin Fc Fragments/therapeutic use, Male, Middle Aged, Myocardial Infarction/prevention & control, Recombinant Fusion Proteins/therapeutic use, Stroke/prevention & control

Relation: LANCET; J02152; OAK-2019-06489; https://ir.ymlib.yonsei.ac.kr/handle/22282913/174490; https://www.sciencedirect.com/science/article/pii/S0140673619311493; T201904320; LANCET, Vol.394(10193) : 121-130, 2019

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/174490
https://doi.org/10.1016/S0140-6736(19)31149-3
https://www.sciencedirect.com/science/article/pii/S0140673619311493